Categories
Latest News Israel News Top Stories

Salistick: World’s First Saliva Pregnancy Test Hits Sydney Pharmacy Shelves

The development marks the biggest breakthrough in pregnancy testing since the 1960s.

The world’s first saliva pregnancy test is now available on Sydney pharmacy shelves, marking the first major breakthrough in pregnancy testing since at-home urine tests were introduced in the 1960s.

The innovative mouth swab detects the presence of HCG, the pregnancy hormone, offering women a new alternative to traditional testing methods.

Salistick claims the saliva test has a 95 per cent accuracy rate, making it a reliable option for women seeking to confirm pregnancy.

The groundbreaking technology has already gained international recognition, with Time Magazine naming it as one of the best inventions of 2023.

About Salignostics

Salignostics develops fast, safe, user-friendly, and cost-effective saliva-based diagnostic solutions. Its cutting-edge technology processes saliva into an analyzable body fluid, offering fast, safe, user-friendly, and cost-effective diagnostic options for self-testing, homecare, point-of-care, and laboratory settings.

This addresses the limitations of current diagnostic methods which are expensive, time-consuming, and personnel dependent. Our products facilitate easy saliva self-collection, sample preparation, and rapid detection of a wide array of analytes and biomarkers in a single device.

The device can identify human proteins, viral proteins, DNA, and RNA, with the ability to detect a high number of previously unidentifiable biomarkers. This enables non-invasive and painless diagnostics at home.

Salignostics holds 4 innovative patents and 2 trade secrets covering its platform technology. The possibility to collect, detect, and test positions us to address a large group of multi-billion-dollar markets, including the home diagnostics market, projected to grow to $10B by 2032.

In 2023, we have successfully launched Salistick, the first rapid saliva-based pregnancy test, already available in the UK, Sweden, and Israel. Salignostics plans to reach $70M annual revenues by 2030, through expanding its product reach, developing new saliva-based diagnostic applications, and establishing R&D and commercial collaborations with global diagnostics companies.

H/T: Salistick: World’s first saliva pregnancy test hits Sydney pharmacy shelves | 7NEWS

Website: https://www.salignostics.com/

Instagram

youtube.com/shorts/nQukKwnaKPg

For strategic investments, partnerships, and distribution, please email MedTech manager Jeremy Ungar: Jeremy.Ungar@israeltrade.gov.il

Leave a comment